Investors in Stryker Corp (Symbol: SYK) saw new options become available today, for the August 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SYK ...

Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.

Comparing Stryker's Short Interest Against Its Peers Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another ...

The cytoskeleton is an intricate and dynamic fibrous network that has an essential role in the generation and regulation of cell architecture and cellular mechanical properties. The cytoskeleton ...

Stryker SYK recently received FDA clearance for its InCompass Total Ankle System, marking a pivotal expansion in the company's Foot & Ankle portfolio. Designed to address end-stage ankle arthritis ...

Zimmer Biomet just threw down the robotic gauntlet, upgrading its game by acquiring Monogram Technologies to close tech gaps and directly challenge Stryker’s MAKO dominance. This bold strategy mimics ...